Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Micallef

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|September 4, 2004
Clearance of hepatitis C virus after newly acquired infection in injection drug usersMarianne Jauncey, Joanne M Micallef, Stuart Gilmour, et al.
Journal of Viral Hepatitis|May 22, 2015
Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS studyM Alavi, M Micallef, E Fortier, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patientsStephen M Ansell, Susan M Geyer, Matthew J Maurer, et al.
The American Journal of Medicine|December 3, 2002
Stem cell transplantation for the management of primary systemic amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Cancer|November 14, 2006
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphomaIvana N M Micallef, Brad S Kahl, Matthew J Maurer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasiaD M Lillington, I N M Micallef, E Carpenter, et al.
Bone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the proteinS Ushio, M Namba, T Okura, et al.
Blood|April 14, 2009
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F DiPersio, Edward A Stadtmauer, Auayporn Nademanee, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|September 4, 2004
Clearance of hepatitis C virus after newly acquired infection in injection drug usersMarianne Jauncey, Joanne M Micallef, Stuart Gilmour, et al.
Journal of Viral Hepatitis|May 22, 2015
Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS studyM Alavi, M Micallef, E Fortier, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patientsStephen M Ansell, Susan M Geyer, Matthew J Maurer, et al.
The American Journal of Medicine|December 3, 2002
Stem cell transplantation for the management of primary systemic amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Cancer|November 14, 2006
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphomaIvana N M Micallef, Brad S Kahl, Matthew J Maurer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasiaD M Lillington, I N M Micallef, E Carpenter, et al.
Bone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the proteinS Ushio, M Namba, T Okura, et al.
Blood|April 14, 2009
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F DiPersio, Edward A Stadtmauer, Auayporn Nademanee, et al.
Pageof 7